ACQUISITIONS - Schedule of the Purchased Intangible Assets Acquired (Details) - Amicus Therapeutics $ in Thousands |
Apr. 27, 2026
USD ($)
|
|---|---|
| Intangible Asset, Finite-Lived, Acquired [Line Items] | |
| Total intangible assets | $ 4,750,000 |
| IPR&D - BMN 820 | |
| Intangible Asset, Finite-Lived, Acquired [Line Items] | |
| Indefinite lived intangible assets | $ 300,000 |
| Commercialized pharmaceutical product – GALAFOLD | |
| Intangible Asset, Finite-Lived, Acquired [Line Items] | |
| Estimated Useful Life (in Years) | 11 years |
| Finite-lived intangible assets | $ 3,000,000 |
| Commercialized pharmaceutical product – POMBILITI + OPFOLDA | |
| Intangible Asset, Finite-Lived, Acquired [Line Items] | |
| Estimated Useful Life (in Years) | 12 years |
| Finite-lived intangible assets | $ 1,450,000 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average period of amortization for finite-lived intangible asset acquired in business combination, asset acquisition, and from joint venture formation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of identifiable indefinite-lived intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of identifiable finite-lived intangible asset acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|